Treximet Tablet, Film Coated
NDC Package 42847-850-09

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Treximet (sumatriptan succinate and naproxen sodium) tablets is this combination product contains two ingredients: naproxen and sumatriptan. This formulation utilizes a tablet, film coated delivery system. Marketed by Currax Pharmaceuticals Llc, this product is identified by NDC 42847-850 and is authorized under FDA application NDA021926.

Identification & Billing

NDC Package Code
42847-850-09
Package Description
9 TABLET, FILM COATED in 1 BOTTLE
Product Code
42847-850
11-Digit Billing Format
42847085009
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
9 EA
RxNorm Crosswalk
  • RxCUI: 849450 - SUMAtriptan 85 MG / naproxen sodium 500 MG Oral Tablet
  • RxCUI: 849450 - naproxen sodium 500 MG / sumatriptan 85 MG Oral Tablet
  • RxCUI: 849450 - naproxen sodium 500 MG / sumatriptan (as sumatriptan succinate) 85 MG Oral Tablet
  • RxCUI: 849452 - Treximet 85 MG / 500 MG Oral Tablet
  • RxCUI: 849452 - naproxen sodium 500 MG / sumatriptan 85 MG Oral Tablet [Treximet]

Clinical Specifications

Proprietary Name
Treximet
Non-Proprietary Name
Sumatriptan Succinate And Naproxen Sodium
Substance Name
Naproxen Sodium; Sumatriptan Succinate
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
This combination product contains two ingredients: naproxen and sumatriptan. It helps to relieve headache, pain, and other migraine symptoms (including nausea, vomiting, sensitivity to light/sound) in adults and in children 12 years or older. Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications. Naproxen is known as a nonsteroidal anti-inflammatory drug (NSAID). It is used to relieve pain. Sumatriptan belongs to a class of drugs called triptans. It affects a certain natural substance (serotonin) that causes narrowing of blood vessels in the brain. It may also relieve pain by affecting certain nerves in the brain. This medication does not prevent future migraines or lessen how often you get migraine attacks.

Regulatory & Marketing

Labeler Name
Currax Pharmaceuticals Llc
Product Type
Human Prescription Drug
FDA Application #
NDA021926
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
04-25-2008
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 42847-850-09 identifies a specific commercial package of 9 tablet, film coated in 1 bottle of Treximet, a human prescription drug labeled by Currax Pharmaceuticals Llc. This tablet, film coated is formulated for oral use and contains naproxen sodium; sumatriptan succinate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Currax Pharmaceuticals Llc on April 25, 2008. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This combination product contains two ingredients: naproxen and sumatriptan. It helps to relieve headache, pain, and other migraine symptoms (including nausea, vomiting, sensitivity to light/sound) in adults and in children 12 years or older. Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications. Naproxen is known as a nonsteroidal anti-inflammatory drug (NSAID). It is used to relieve pain. Sumatriptan belongs to a class of drugs called triptans. It affects a certain natural substance (serotonin) that causes narrowing of blood vessels in the brain. It may also relieve pain by affecting certain nerves in the brain. This medication does not prevent future migraines or lessen how often you get migraine attacks.

How is this Currax Pharmaceuticals Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 42847085009. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 9 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
42847-850-09
11-Digit CMS (5-4-2)
42847-0850-09

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.